Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
|3||Not yet recruiting||
Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia
Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion
STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
Extension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML)
† Study has passed its completion date and status has not been verified in more than two years.